Citation:
Vasic, R. , Shi, Y. , Arruda, A. , Malik, S. , Claudio, J. , Capo-Chichi, J. - M. , Bankar, A. , et al. (2020). Clinical Significance of Emergent Leukocytosis in Patients with Myelofibrosis Receiving JAK Inhibitor Therapy. In Blood. Retrieved from https://doi.org/10.1182/blood-2020-139936
